hotspot -WSS

hotspot

author：fashion 2025-09-05 13:46:10 - browse：23184

What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week. Then, we dive into the fascinating world of fetal genome surgery, as STAT’s Megan Molteni joins us to explain the work of a scientist named Tippi MacKenzie.

For more on what we cover, here’s the news on Gonzalez; here’s the story on MacKenzie; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： UCB departs biotech trade group BIO

WSS

U.K. sequencing study surfaces new findings about tumor DNA

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

JPM: CVS says Medicare Advantage patients are impacting profits

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Medicare Advantage plans can’t deny care with AI, CMS warns

focus

hotspot

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Federal weight loss drug coverage is 30 years out of date

United colonoscopy coverage change 'may cost lives,' doctors say

The biotech scorecard for Q1: 17 stock

Bright Health sells Medicare Advantage business to Molina

AI gets buy

Drug repurposing or repositioning? The language matters

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

The cancer drug shortage isn’t new — and neither are the solutions

Videos point to link between seizures and unexplained toddler deaths

hotspot

Why Novartis is going to walk from its acquisition of MorphoSys

3 medical device trends to watch in 2024

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Videos point to link between seizures and unexplained toddler deaths

knowledge

knowledge

knowledge

hotspot